Literature DB >> 7687319

Granulocyte and granulocyte-macrophage colony-stimulating factors.

W P Steward1.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 7687319     DOI: 10.1016/0140-6736(93)91350-u

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) in healthy male volunteers.

Authors:  A C Houston; L A Stevens; V Cour
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

2.  Granulocyte macrophage-colony stimulating factor (GM-CSF) in neonatal neutropenia.

Authors:  M Ray; K Mukhopadhyay; A Narang
Journal:  Indian J Pediatr       Date:  2000-01       Impact factor: 1.967

3.  A proposal for deciding when to prophylactically administer bone marrow (granulocyte) stimulatory factors to patients receiving cytotoxic chemotherapy.

Authors:  M Markman
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Pharmacokinetics of a hematoregulatory peptide (SK&F107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapy.

Authors:  P Zia-Amirhosseini; R Z Harris; H C Cowley; J W Valle; D R Citerone; V K Boppana; H Scarffe; P Watson; C B Davis
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

Review 5.  Colony-stimulating factors. Present status and future potential.

Authors:  R M Fox
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

6.  Novel immunological pathways to the treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

7.  Recombinant haemopoietic growth factors in the newborn--will they be useful?

Authors:  C A Wardrop; B M Holland
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

8.  Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity.

Authors:  C T McGary; M E Miele; D R Welch
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

9.  The effects of short-term use of granulocyte colony-stimulating factor on bone metabolism in child cancer patients.

Authors:  Ayse Bozkurt Turhan; Cigdem Binay; Ozcan Bor; Enver Simsek
Journal:  North Clin Istanb       Date:  2018-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.